PHARMAC - Latest News [Page 26]
Transparency call in British parliamentary inquiry
Wednesday, 7 December 2005, 10:22 am | PHARMAC
A British Parliamentary Committee has called for more openness and transparency from groups and agencies linked to the pharmaceutical industry. Former British Medical Journal editor Dr Richard Smith, writing in PHARMAC’s 2005 Annual Review, says the ... More >>
PHARMAC heart campaign continues to grow
Wednesday, 7 December 2005, 9:28 am | PHARMAC
The One Heart Many Lives campaign is continuing to grow and produce positive results, says PHARMAC Medical Director Dr Peter Moodie. More >>
Cancer drug funding a challenge – PHARMAC
Tuesday, 6 December 2005, 10:18 am | PHARMAC
Planning and budgeting for new cancer treatments provides one of PHARMAC’s biggest challenges for the future, says PHARMAC’s Medical Director Dr Peter Moodie. More >>
PHO impact seen in subsidised prescribing jump
Tuesday, 6 December 2005, 10:17 am | PHARMAC
The number of prescriptions subsidised by the Government has climbed to an all-time high, figures from drug-funding agency PHARMAC show. More >>
Spending on target, patient numbers growing
Tuesday, 6 December 2005, 8:58 am | PHARMAC
Nearly 7000 people were treated with newly-subsidised medicines as a result of funding decisions made in the 2004-2005 year, figures released today by Government drug funder PHARMAC show. More >>
SSRI prescribing up 9.7 percent despite warnings
Tuesday, 6 December 2005, 12:39 am | PHARMAC
Prescribing of new-generation antidepressants continues to grow strongly, figures issued today by government drug funder PHARMAC show. More >>
New Year, new drug for arthritis patients
Monday, 5 December 2005, 11:09 am | PHARMAC
People with severe rheumatoid arthritis will have a new subsidised treatment in the New Year following a decision by government drug-funding agency PHARMAC. More >>
Full funding for cardiac treatments
Wednesday, 30 November 2005, 11:34 am | PHARMAC
People wanting to reduce their chances of suffering from heart attack or stroke are to have two more fully-funded treatments available. More >>
Cost less of a barrier to medicines in NZ: Report
Monday, 28 November 2005, 8:49 am | PHARMAC
Cost is less likely to be a barrier to New Zealanders accessing medicines than people in comparable countries, a study by US-based health researcher the Commonwealth Fund shows. More >>
PHARMAC funds new treatment for multiple sclerosis
Tuesday, 22 November 2005, 11:37 am | PHARMAC
A new treatment for multiple sclerosis will be funded from 1 December, Government drug-funder PHARMAC announced today. More >>
Two new treatments funded for Parkinson’s disease
Thursday, 27 October 2005, 1:17 pm | PHARMAC
Two new treatments will be subsidised from 1 November for people with Parkinson’s disease, government drug-funder PHARMAC announced today. More >>
Asthma patients to breathe easier
Thursday, 20 October 2005, 11:28 am | PHARMAC
Government drug-funder PHARMAC has announced a decision to widen access to salmeterol (Serevent) asthma inhalers, one of the group of treatments known as long-acting beta agonists (LABAs). These are used by people whose asthma is not adequately controlled ... More >>
More people to get transplant drug
Thursday, 29 September 2005, 11:16 am | PHARMAC
People who have had kidney or heart transplants will be able to have ongoing access to the anti-rejection drug mycophenolate from 1 October, Government drug-funder PHARMAC announced today. More >>
Alendronate to be subsidised
Tuesday, 27 September 2005, 12:26 am | PHARMAC
Many more people with osteoporosis will be able to have subsidised access to alendronate from 1 October 2005. More >>
Injection to aid treatment of mental illness
Thursday, 8 September 2005, 12:46 am | PHARMAC
Patients living with psychoses will have a new funded treatment option from 1 October 2005, with PHARMAC’s decision to list the injectable form of the antipsychotic medicine risperidone. More >>
Pfizer report reveals drug company agenda
Tuesday, 30 August 2005, 5:23 pm | PHARMAC
A report issued today reveals the drug industry wants patients to pay more for their drugs, and for services such as elective surgery to be cut. More >>
GP prescribing gives easier access to two drugs
Monday, 15 August 2005, 2:39 pm | PHARMAC
Changes to access criteria by drug funding agency PHARMAC will see the antidepressant venlafaxine (Efexor XR) and the anti-fungal treatment terbinafine (Lamisil) able to be prescribed by general practitioners. More >>
One step means less paperwork for cholesterol drug
Monday, 8 August 2005, 11:12 am | PHARMAC
Government drug-funder PHARMAC is giving patients easier long-term access to the cholesterol-lowering drug atorvastatin (Lipitor) and reducing the workload of clinicians in the process. More >>
Easier access to glaucoma drops
Thursday, 4 August 2005, 3:04 pm | PHARMAC
People with the progressive eye disease glaucoma will find it easier to obtain eye drops under changes being made by PHARMAC. More >>
Diabetes treatment more widely available
Monday, 1 August 2005, 10:08 am | PHARMAC
Government drug funder PHARMAC is giving more people the chance to have the new generation diabetes treatment pioglitazone (Actos). More >>
